drugset / Trial / NCT01455870
A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 3 study to compare treatment with ITCA 650 to sitagliptin when added to metformin monotherapy in patients with type 2 diabetes.
Timeline
- Start
- 2013-05
- Primary completion
- 2015-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 60 ug | — |
| Comparator | Sitagliptin | Small molecule | 100 mg | Oral |